Oncology Unscripted with John Marshall, MD brings you a unique take on the latest oncology news including business news, gossip, science, and a special in-depth segment relevant to clinical practice.
All content for Oncology Unscripted With John Marshall is the property of John Marshall and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Oncology Unscripted with John Marshall, MD brings you a unique take on the latest oncology news including business news, gossip, science, and a special in-depth segment relevant to clinical practice.
Oncology Unscripted With John Marshall: Episode 13: From Science to Survival: Dr Marshall Sounds the Alarm on the Dangerous Freeze on Cancer Research
Oncology Unscripted With John Marshall
17 minutes 52 seconds
9 months ago
Oncology Unscripted With John Marshall: Episode 13: From Science to Survival: Dr Marshall Sounds the Alarm on the Dangerous Freeze on Cancer Research
Dr Marshall highlights practice-changing research at ASCO GI (#GI25) and discusses the turmoil caused by the new presidential administration’s abrupt policy changes, which have disrupted federal health agencies, including the NIH and NCI. He shares his views on the impacts of grant freezes, research funding uncertainty, and restrictions on federal scientists, warning that these decisions jeopardize cancer research progress and patient care.
Dr Marshall reflects on the emotional toll of ongoing uncertainty in healthcare, particularly the impact on both providers and patients. While doctors must stay strong for their patients, they too are grappling with anxiety about the future of research, funding, and patient care. He emphasizes the need for support among colleagues, urging teams to check in with each other so they can continue providing the best care possible.
Oncology Unscripted With John Marshall
Oncology Unscripted with John Marshall, MD brings you a unique take on the latest oncology news including business news, gossip, science, and a special in-depth segment relevant to clinical practice.